Depressive Disorder Market - Pfizer Inc., AstraZeneca, Eli Lilly, Lundbeck Discussed in 2016 Report

Sep 07, 2016, 12:45 ET from Market Reports Online

PUNE, India, September 7, 2016 /PRNewswire/ -- adds "Global Depressive Disorder Market: Industry Analysis & Outlook (2016-2020)" research report to the pharmaceuticals intelligence collection of its research store. The US has highest depression disorder prevalence along with highest prevalence of bipolar depression & schizophrenia.

The report offers an in-depth analysis of the "Global Depressive Disorder Market" segmented into global and regional markets. Competition is concentrated in the hands of few major pharmaceutical companies out of which Pfizer Inc., AstraZeneca, Eli Lilly and company, and Lundbeck have been covered in the report.

Complete report on Depressive disorder market spread across 57 pages providing 4 company profiles and 8 Tables and 46 Charts is now available at

Depression is a serious mood disorder, affecting the ability to think, feel, and handle situations like sleeping, eating, or working. It is a mood disorder that causes a persistent feeling of sadness and loss of interest. It builds up a very negative perspective in the way of thinking in every single thing and damages a person's ability to see brighter versions of any situation in life. It is of various types like major depressive disorder (MDD), perinatal depression, psychotic depression, seasonal depression and bipolar depression.

To be diagnosed with depression, the symptoms must be present for at least two weeks. It may require long-term treatment for years. There is no single cause of depression; it is likely an outcome from combinations of genetic, biochemical, environmental and physiological factors. There are several ways of treating depression depending upon each individual's characteristics & symptoms. Most people feel better with medication, psychological counseling or both.

The global depressive disorder market is expected to grow and overcome falling revenues due to patent expiry with better innovative drugs and therapies. The US has highest depression disorder prevalence along with highest prevalence of bipolar depression & schizophrenia. With growing awareness and better access to medical facilities, the depressive disorder market is expected to grow worldwide, especially in Asia-Pacific region.

Company coverage of Depressive Disorder Market: Pfizer Inc., AstraZeneca, Lundbeck & Eli Lilly and Company

The key factors driving the growth of the depressive disorder market includes increased smoking prevalence, rising healthcare expenditure, growing female population, increasing spending on medicines and rising number of prescription drugs. However, there are certain factors hindering the growth of the market like patent expiry, severe side effects of drugs, and tough regulations. Major trends of the market include novel drug approvals, major drugs in pipeline, and growing public awareness.

Purchase a copy of this "Global Depressive Disorder Market: Industry Analysis & Outlook" research report at USD 800 (Single User License)

DataPack Available of Depressive Disorder Market at

Few Points from List of Tables & Charts Provided in Global Depressive Disorder Market:

Novel Drug Approvals for Depression Disorder (2015)

Major Rapid Acting Depression Drugs in Development (2015)

Severe Side-Effects of Depression Disorder Drugs

Global Anti-Depressants Market Comparison by Product Profile (2015)

Global Anti-Psychotics Market Comparison by Product Profile (2015)

New Products of Pfizer with FDA Approval (2015/2016)

Approvals and Upcoming Drugs (2015)

Lundbeck's New Drugs in Development (2015)

Browse All Latest Koncept Analytics Market Research Reports at

About Us:  

Market Reports Online comprises of an online library of 250,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Tel: + 1 888 391 5441

SOURCE Market Reports Online